Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 1/20 | 0.43 |
| ▸ | CTSK | P43235 | 10/20 | 0.42 |
| ▸ | CTSS | P25774 | 7/20 | 0.42 |
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
| ▸ | CTSB | P07858 | 1/20 | 0.40 |
| ▸ | PLK1 | P53350 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | CCKBR | P32239 | 1/20 | 0.35 |
| ▸ | AKT1 | P31749 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17870152 | 0.91 | CTSK (0.49) | CAPN1CTSKCTSSCTSLCTSB | |
| SCHEMBL13921025 | 0.85 | CTSK (0.50) | CAPN1CTSKCTSSCTSLCTSB | |
| SCHEMBL13921014 | 0.85 | CTSK (0.50) | CAPN1CTSKCTSSCTSLCTSB | |
| SCHEMBL17870153 | 0.82 | CTSS (0.42) | CAPN1CTSKCTSSCTSLCTSB | |
| SCHEMBL24965950 | 0.80 | CTSK (0.50) | CAPN1CTSKCTSSCTSLCTSB | |
| SCHEMBL19401696 | 0.80 | CTSK (0.50) | CAPN1CTSKCTSSCTSLCTSB | |
| SCHEMBL17870155 | 0.79 | CTSK (0.47) | CAPN1CTSKCTSSCTSLCTSB | |
| SCHEMBL13567291 | 0.79 | CTSS (0.51) | CAPN1CTSKCTSSCTSLCTSB | |
| SCHEMBL17880449 | 0.77 | CTSK (0.45) | CAPN1CTSKCTSSCTSLCTSB | |
| SCHEMBL17880447 | 0.77 | CTSK (0.52) | CAPN1CTSKCTSSCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160185821-A1 | Z-SELECTIVE OLEFIN METATHESIS OF PEPTIDES | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160185821-A1 | Z-SELECTIVE OLEFIN METATHESIS OF PEPTIDES | QPCT, PTMS, MAX | CAPN1 2666/4885CTSK 194/4885CTSS 203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.